Healthcare provider profile · identity verified

John Anthony Carroll, MD

Geriatric Medicine · SCOTTSDALE, AZ · NPI 1063468932

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	413	75
Eliquis	Apixaban	296	39
Gabapentin	Gabapentin	285	61
Levothyroxine Sodium	Levothyroxine Sodium	227	49
Furosemide	Furosemide	209	42
Ondansetron Hcl	Ondansetron Hcl	189	44
Sertraline Hcl	Sertraline Hcl	175	38
Trazodone Hcl	Trazodone Hcl	171	33
Pantoprazole Sodium	Pantoprazole Sodium	157	43
Tamsulosin Hcl	Tamsulosin Hcl	137	29
Mirtazapine	Mirtazapine	125	34
Levetiracetam	Levetiracetam	124	21
Potassium Chloride	Potassium Chloride	121	26
Metoprolol Tartrate	Metoprolol Tartrate	114	24
Carvedilol	Carvedilol	113	27
Hydralazine Hcl	Hydralazine Hcl	106	20
Lisinopril	Lisinopril	99	25
Metformin Hcl	Metformin Hcl	95	22
Buspirone Hcl	Buspirone Hcl	90	22
Escitalopram Oxalate	Escitalopram Oxalate	90	16
Amlodipine Besylate	Amlodipine Besylate	81	32
Clopidogrel	Clopidogrel Bisulfate	80	21
Lantus	Insulin Glargine,hum.Rec.Anlog	80	19
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	73	23
Jardiance	Empagliflozin	69	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	16
Lactulose	Lactulose	59	11
Divalproex Sodium	Divalproex Sodium	55	15
Insulin Lispro	Insulin Lispro	55	15
Nifedipine Er	Nifedipine	55	12
Losartan Potassium	Losartan Potassium	54	16
Baclofen	Baclofen	53	14
Prednisone	Prednisone	50	22
Spironolactone	Spironolactone	49	12
Albuterol Sulfate Hfa	Albuterol Sulfate	48	28
Carbidopa-Levodopa	Carbidopa/Levodopa	48	suppressed
Omeprazole	Omeprazole	48	14
Oxycodone Hcl	Oxycodone Hcl	47	17
Montelukast Sodium	Montelukast Sodium	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	12
Januvia	Sitagliptin Phosphate	43	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	40	18
Memantine Hcl	Memantine Hcl	40	suppressed
Midodrine Hcl	Midodrine Hcl	40	18
Rosuvastatin Calcium	Rosuvastatin Calcium	40	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	39	19
Metoprolol Succinate	Metoprolol Succinate	39	15
Risperidone	Risperidone	39	suppressed
Finasteride	Finasteride	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	16
Glipizide	Glipizide	36	suppressed
Trulicity	Dulaglutide	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	19
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Nystatin	Nystatin	32	19
Pregabalin	Pregabalin	32	suppressed
Bumetanide	Bumetanide	30	11
Clonidine Hcl	Clonidine Hcl	30	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	16
Hydroxyzine Hcl	Hydroxyzine Hcl	28	15
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Xifaxan	Rifaximin	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Digoxin	Digoxin	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	14
Aripiprazole	Aripiprazole	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Dilantin	Phenytoin Sodium Extended	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Topiramate	Topiramate	21	suppressed
Carbamazepine	Carbamazepine	19	suppressed
Klor-Con 10	Potassium Chloride	19	suppressed
Savella	Milnacipran Hcl	19	suppressed
Primidone	Primidone	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	17	suppressed
Calcitriol	Calcitriol	16	suppressed
Colchicine	Colchicine	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	14	suppressed
Risperidone Odt	Risperidone	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	suppressed
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Theophylline Er	Theophylline Anhydrous	13	suppressed
Xiidra	Lifitegrast	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Theo-24	Theophylline Anhydrous	12	suppressed
Torsemide	Torsemide	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Lamotrigine Er	Lamotrigine	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error